Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer

doi:10.3748/wjg.v21.i10.2988

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 10

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8020)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

439

WORD

241

HTML

4953

Figures (1-3)

517

Tables (1-3)

175

Sum=6325

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

624

Download

1071

Sum=1695

Mar 14, 2015 (publication date) through Jul 24, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Mar 14, 2015; 21(10): 2988-2996
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.2988

Table 3 Performances of contrast-enhanced computed tomography, positron emission tomography/computed tomography, and positron emission tomography/contrast-enhanced computed tomography fusion images in the stage assessments of pancreatic cancer n (%)

	Peripancreatic vessel invasion					Regional lymph node metastasis					Distant metastasis
	SEN	SPE	PPV	NPV	ACC	SEN	SPE	PPV	NPV	ACC	SEN	SPE	PPV	NPV	ACC
CECT	14 (93.3)	15 (93.8)	14 (93.3)	15 (93.8)	29 (93.5)	12 (63.2)	11 (91.7)	12 (92.3)	11 (61.1)	23 (74.2)	10 (58.8)	33 (100)	10 (100)	33 (82.5)	43 (86.0)
Routine PET/CT	4 (26.7)	12 (75.0)	4 (50)	12 (52.2)	16 (51.6)	15 (78.9)	10 (83.3)	15 (88.2)	10 (71.4)	25 (80.6)	14 (82.4)	30 (90.9)	14 (82.4)	30 (90.9)	44 (88)
PET/CECT	14 (93.3)	15 (93.8)	14 (93.3)	15 (93.8)	29 (93.5)	17 (89.5)	11 (91.7)	17 (94.4)	11 (84.6)	28 (90.3)	16 (94.1)	32 (97.0)	16 (94.1)	32 (97.0)	48 (96.0)
PET/CECT vs PET/CT	χ² = 13.889 P = 0.001	χ² = 2.133 P = 0.144	χ² = 5.759 P = 0.016	χ² = 7.657 P = 0.006	χ² = 13.697 P = 0.001	χ² = 0.792 P = 0.374	χ² = 0.381 P = 0.537	χ² = 0.430 P = 0.512	χ² = 0.678 P = 0.410	χ² = 1.170 P = 0.279	χ² = 1.133 P = 0.287	χ² = 1.065 P = 0.302	χ² = 1.133 P = 0.287	χ² = 1.065 P = 0.302	χ² = 2.174 P = 0.140
PET/CECT vs CECT	χ² = 0.000 P = 1.000	χ² = 0.000 P = 1.000	χ² = 0.000 P = 1.000	χ² = 0.000 P = 1.000	χ² = 0.000 P = 1.000	χ² = 3.640 P = 0.056	χ² = 0.000 P = 1.000	χ² = 0.057 P = 0.811	χ² = 2.024 P = 0.155	χ² = 2.763 P = 0.096	χ² = 5.885 P = 0.015	χ² = 1.015 P = 0.314	χ² = 0.611 P = 0.434	χ² = 3.880 P = 0.049	χ² = 3.053 P = 0.081

PET/CT: Positron emission tomography/computed tomography; CECT: Contrast-enhanced CT; SEN: Sensibility; SPE: Specificity; PPV: Positive predictive value; NPV: Negative predictive value; ACC: Accuracy.

Citation: Zhang J, Zuo CJ, Jia NY, Wang JH, Hu SP, Yu ZF, Zheng Y, Zhang AY, Feng XY. Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer. World J Gastroenterol 2015; 21(10): 2988-2996
URL: https://www.wjgnet.com/1007-9327/full/v21/i10/2988.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i10.2988